Cardiac Biomarkers Market

Cardiac Biomarkers Market Size, Share, Growth Analysis, By Product (Troponin, CK-MB), By Application (Acute Coronary Syndrome, Myocardial Infarction), By Location of Testing, By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2951 | Region: Global | Published Date: November, 2024
Pages: 199 | Tables: 92 | Figures: 71

Cardiac Biomarkers Market Insights

Global Cardiac Biomarkers Market size was valued at USD 9.42 billion in 2022 and is poised to grow from USD 10.61 billion in 2023 to USD 27.56 billion by 2031, growing at a CAGR of 12.67% during the forecast period (2024-2031).

Cardiac biomarkers are the elements released in blood when the patient’s heart is stressed or damaged. They are necessary for managing and diagnosing different heart associated disorders like heart failures, heart attacks, and more. The cardiac biomarkers market is significantly driven by the growing incidences of heart diseases, increasing awareness regarding the benefits of early diagnosis, mounting demand for personalized medicines, and improvements in biomarker technologies. However, the market is restrained by costly advanced biomarker testing and lack of standardization, leading to variations in test results. Overall, the market is projected to continue progressing due to the growing number of innovations, higher emphasis on preventive healthcare, and rising healthcare expenditure.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Cardiac Biomarkers Market size was valued at USD 9.42 billion in 2022 and is poised to grow from USD 10.61 billion in 2023 to USD 27.56 billion by 2031, growing at a CAGR of 12.67% during the forecast period (2024-2031).

The global cardiac biomarkers market is a highly competitive global market driven by many international competitors. Prominent corporations with cutting-edge AI and ML technology are Google, IBM, Microsoft, and NVIDIA. To support a wide range of applications across industries, these industry experts concentrate on creating cutting-edge algorithms, scalable platforms, and reliable infrastructure. Rapid advances in technology, strategic alliances, and large expenditures on research and development define the competitive environment. 'Abbott ', 'QuidelOrtho Corporation ', 'Siemens AG ', 'F. Hoffmann-La Roche Ltd. ', 'Danaher Corporation ', 'Biomérieux SA ', 'Bio-Rad Laboratories, Inc. ', 'Randox Laboratories Ltd. ', 'Creative Diagnostics ', 'Life Diagnostics ', 'Thermo Fisher Scientific ', 'Becton, Dickinson and Company ', 'DiaSorin ', 'Myriad RBM ', 'Mindray Medical International Limited  ', 'ReLIA Diagnostic Systems ', 'Merck KGaA ', 'Quanterix Corporation ', 'Eurofins Scientific ', 'Inova Diagnostics'

Focus on Preventive Healthcare and Early Diagnosis

Growing Use of Multi-Biomarker Panels: Recent years have witnessed increased use of panels of biomarkers. This inclination towards biomarker panels rather than single markers is trending in the market. These panels offer a highly exhaustive evaluation of cardiovascular risks relating to stress, cardiac injury, and inflammation. Multi-biomarkers methods are currently being explored to improve risk stratification, mainly in complicated cases where single biomarkers may not offer enough data.

Geographically, North America is the dominating region among others and is expected to lead over the forecast period owing to improved healthcare infrastructure with advanced diagnostic technologies and increased adoption of novel medical solutions. Also, the rising incidences of heart disorders in the region are rigorously demanding effective diagnostic solutions. Regional growth is further impacted by robust R&D along with strong network of clinical and academic research institutes, driving improvements in biomarker technologies. The leading players operating in the region include Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, Beckman Coulter, Quidel Corporation, and more.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Cardiac Biomarkers Market

Report ID: SQMIG35A2951

$5,300
BUY NOW GET FREE SAMPLE